NEO-MEDROL ACETATE
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
Approval overview NEO-MEDROL ACETATE is listed in Drugs@FDA under application 060611 (ANDA).
Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.25%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEO-MEDROL ACETATE is listed in Drugs@FDA under application 060611 (ANDA). Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.25%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.